Cencora, Inc.

Low

COR · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries · CIK 0001140859

Latest filing: 10-K · 2025-11-25

Customer concentration

Significant Customers note · revenue dependency

Medium

Top exposure

25%

Walgreens and Boots UK LtdNamed

Other major customers

Evernorth Health Services

13%

Each is a separate customer disclosed individually — the figures are not sub-parts of the headline and may be measured against different revenue bases, so they are not additive.

Flat

Click a point to open the SEC source

Geographic concentration

Segment reporting · geographic revenue

Low

Top exposure

<10%

No disclosure detected

Flat

Supplier concentration

Risk Factors · supply chain dependency

Low

Dependency

Single source

Single sourceNamed

Qualitative disclosure — no % quantified (informational, not scored)

Flat

FY25

Qualitative dependency level by filing year.

Product concentration

ASC 275 · disclosed dependence on a specific product or service

Low

Top exposure

<10%

No disclosure detected

Flat

Credit concentration

ASC 825 · concentration of credit risk note

Medium

Receivables

38%

Walgreens and Boots UK Ltd

Flat

Click a point to open the SEC source